Dotbee.ai

Analysis AlloVir, Inc. (ALVR)

6/3/2024

Analysis AlloVir, Inc. (ALVR)

Analysis of AlloVir, Inc. (ALVR)

AlloVir, Inc. is showing some interesting price movements and technical indicators based on the provided data:

1. Price Movement:
- The closing price has been fluctuating between 0.740 and 0.779 over the past few days.
- There seems to be some resistance around the 0.780 level, as the price has struggled to break above it.

2. Technical Indicators:
- RSI Indicator: The Relative Strength Index (RSI) values are hovering around 45-50, indicating a neutral sentiment in the market.
- MACD Indicator: The MACD line is slightly below the signal line, suggesting a potential bearish signal.
- Moving Averages: The Simple Moving Average (SMA), Exponential Moving Average (EMA), and Weighted Moving Average (WMA) are all close to each other, indicating a consolidation phase.

3. Overall, AlloVir, Inc. seems to be in a consolidation phase with no clear trend direction. Traders and investors may want to wait for a breakout above the resistance level at 0.780 or a breakdown below the support level at 0.740 to confirm a new trend direction before making any trading decisions.

Earnings

The company's results for the most recent quarter ending on April 30, 2025, have not been provided at this time. The previous results were reported on February 27, 2025, through the Transfer Agent. Before that, on January 31, 2025, the results were released after hours. The results for October 31, 2024, were not provided at the time. On August 1, 2024, the company reported an earnings per share (EPS) estimate of 1.32.

Main Statystic 🧠

The data provided includes financials, stock statistics, valuation metrics, stock price summary, and dividends and splits information for a specific company.

In terms of financials, the company has strong operating cash flow and levered free cash flow, with a positive current ratio and a high total debt to equity ratio. The profit margin and operating margin are also healthy, indicating efficient operations. The company's fiscal year ends in September 2023, and the most recent quarter reported is March 31, 2024. The company shows good returns on assets and equity.

In terms of stock statistics, the company has a low short ratio and a significant percentage of shares held by institutions. The stock price summary shows volatility with a beta of 1.264 and a 52-week change of 6.853%.

Valuation metrics indicate a high PEG ratio and price to book ratio, with the company being relatively expensive based on these metrics. The company's market capitalization and enterprise value are substantial.

Lastly, the dividends and splits information shows a history of dividends and a recent split in August 2020. The company has a forward annual dividend rate and yield, as well as a trailing annual dividend rate and yield.

Earnings estimate

Based on the analysts' estimates for future quarterly and annual earnings per share:

1. For the current quarter ending on June 30, 2024, the average EPS estimate is $1.23, with a low estimate of $1.18 and a high estimate of $1.26. This shows an improvement compared to the EPS of $1.17 from the same quarter a year ago.

2. For the next quarter ending on September 30, 2024, the average EPS estimate is $1.42, with a low estimate of $1.33 and a high estimate of $1.51. This also indicates growth from the EPS of $1.35 in the same quarter last year.

3. Looking at the estimates for the current year ending on September 30, 2024, the average EPS estimate is $6.10, ranging from a low estimate of $5.95 to a high estimate of $6.41. This reflects an increase from the EPS of $5.67 for the previous year.

4. For the next year ending on September 30, 2025, the average EPS estimate is $6.69, with a low estimate of $5.92 and a high estimate of $7.31. This suggests a slight improvement from the EPS of $6.10 in the previous year.

Overall, the analysts' estimates point towards a positive trend of increasing earnings per share for the company in both the short term and the long term.

Revenue estimate

The analysts' estimates for the future quarterly and annual sales of the company are as follows:

1. **Current Quarter (as of June 30, 2024):**
- Average Estimate: $77,545,400,000
- Low Estimate: $75,869,000,000
- High Estimate: $79,035,500,000
- Sales Growth from a year ago: 2%
- Number of Analysts: 25
- Year Ago Sales: $75,725,200,000

2. **Next Quarter (as of September 30, 2024):**
- Average Estimate: $85,501,800,000
- Low Estimate: $81,634,900,000
- High Estimate: $91,144,800,000
- Sales Growth from a year ago: 3%
- Number of Analysts: 25
- Year Ago Sales: $82,854,600,000

3. **Current Year (as of September 30, 2024):**
- Average Estimate: $357,772,000,000
- Low Estimate: $350,189,000,000
- High Estimate: $364,505,000,000
- Sales Growth from a year ago: 1%
- Number of Analysts: 38
- Year Ago Sales: $354,834,000,000

4. **Next Year (as of September 30, 2025):**
- Average Estimate: $380,772,000,000
- Low Estimate: $353,721,000,000
- High Estimate: $403,636,000,000
- Sales Growth from a year ago: 6%
- Number of Analysts: 38
- Year Ago Sales: $357,772,000,000

**Key Takeaways:**
- The analysts are generally forecasting a moderate growth in sales for both the current and next quarters, with higher growth expected in the next year.
- The number of analysts providing estimates increases for the annual projections, indicating more interest in the long-term performance of the company.
- Consistent growth is projected in the long term, with a significant increase in sales expected for the next fiscal year compared to the current year.

Growth estimates

Based on the consensus estimates provided:
- The current year growth rate is 7.6%
- The next quarter growth rate is 5.1%
- The current quarter growth rate is 5.1%
- The next year growth rate is 9.7%
- The next 5 years compound annual growth rate (CAGR) is 9.7%
- The past 5 years compound annual growth rate (CAGR) is 20.1%

It can be observed that the company is expected to experience a higher growth rate in the future compared to the past, with a significant decrease in growth from the past 5 years to the next 5 years. Additionally, there is a slight increase in growth expected from the current year to the next year.

Price target

The analysts' forecast for the future price of the security is as follows:
- Low: $164
- High: $275
- Median: $201.43
- Average: $204.58
- Current price: $192.25

Based on these forecasts, it appears that the analysts are generally optimistic about the future price of the security, with a median forecast above the current price. However, there is a wide range of forecasts, from a low of $164 to a high of $275, indicating some uncertainty in the market.

Income statement 💸

Here are the revenue figures for the company over the past four fiscal years:

1. Fiscal Year 2023: Sales of $383,285,000,000
2. Fiscal Year 2022: Sales of $394,328,000,000
3. Fiscal Year 2021: Sales of $365,817,000,000
4. Fiscal Year 2020: Sales of $274,515,000,000

From these figures, we can observe the following trends:
- The company experienced a decrease in sales from FY 2022 to FY 2023.
- Prior to FY 2023, the company had been experiencing a steady increase in sales over the previous years.
- The highest sales figure was recorded in FY 2022.

These trends indicate fluctuations in the company's revenue performance, with a notable decrease in sales in the most recent fiscal year.

Balance Sheet

These are balance sheets. Here are the conclusions:

1. The total assets have been increasing over the years, reaching $365,725,000,000 in 2018.
2. Current assets include cash, inventory, and receivables, with a significant portion in cash equivalents and short-term investments.
3. Non-current assets consist mainly of investments and advances, along with machinery, furniture, and equipment.
4. Total liabilities have also been increasing, but at a slower pace compared to assets.
5. Shareholders' equity has shown a positive trend, indicating a healthy financial position.
6. The company has been investing in leases, land, and improvements over the years.
7. Accumulated depreciation has been significant, affecting the value of non-current assets.
8. Long-term debt is a major component of non-current liabilities.
9. The company has been managing its short-term debt and accounts payable effectively.
10. Retained earnings have fluctuated but have generally shown an increasing trend.

Cash Flow 💶

This is a cash flow statement. Here are some conclusions we can draw from the data:

1. The company's free cash flow has been fluctuating over the years, with the highest value in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing over the years, indicating improved operational efficiency.
3. The company has been consistently paying interest and income taxes, with varying amounts each year.
4. The end cash position has also been fluctuating, reaching its highest value in 2020.
5. Financing activities show a pattern of common stock repurchase, issuance of long-term debt, and payment of dividends.
6. Investing activities include the sale and purchase of investments, as well as capital expenditures.
7. Overall, the company seems to be managing its cash flow effectively, with a focus on operational efficiency and strategic investments.

MACD of ALVR

This is not investment advice. Remember to verify the information provided here.

Get access to the full analysis

  • Over 35 000 indexes
  • CFD, Forex, Crypto and Stocks Exchange
  • Over 150 Indicators
  • Pattern and candle analysis
  • Support and resistance levels
  • Fundamental, technical and sentimental analysis
  • Power from AI
Web versionApp StoreGoogle Play

Contacts

Telephone number

+48 32 700 81 66

Email address

[email protected]

Company information

Honey Payment Group S.A. at Al. Aleje Jerozolimskie 65 / 79, 00-697 Warsaw, Poland, Register number KRS 0000335507, NIP 5252859204, REGON 388760204. Honey Payment Group is listed on the Warsaw Stock Exchange (WSE) under the ticker symbol HPG. Link